非老年成年移植接受者死亡率的年龄修改风险因素:回顾性数据库分析
Alfonso H Santos1, Rohan Mehta2, Kawther Alquadan2
1Division of Nephrology, Hypertension and Renal Transplantation, Department of Medicine, College of Medicine, University of Florida, 1600 SW Archer Road, Medical Science Bldg., Room NG-4, Gainesville, FL, 32610, USA. Alfonso.Santos@medicine.ufl.edu.
International urology and nephrology
|June 26, 2024
概括
50-64岁的移植接受者比年轻人有更低的生存率和更高的死亡风险. 年龄改变了风险因素对非老年移植患者死亡率的影响.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植免疫学 移植免疫学
- 公共卫生 公共卫生
背景情况:
- 移植 (KT) 是对末期病的一种救命手术.
- 非老年成人接受者占KT接受者的很大一部分.
- 了解移植后结果的年龄相关差异对于个性化护理至关重要.
研究的目的:
- 研究受体年龄层 (18-49岁与50-64岁) 如何改变非老年成人移植受体 (KTR) 风险因素和死亡率之间的关联.
主要方法:
- 一组108,695名成年KTR (2000-2016) 具有1年后KT存活率,按移植时的年龄分层 (18-49岁和50-64岁).
- 不包括年龄<18岁或≥65岁的KTR.
- 所有原因的死亡率在5年内被评估 (KT后2-6年).
主要成果:
- 接受者年龄层的增加与KT后6年生存率的下降相关 (79%为18-49岁vs57%为50-64岁).
- 在50-64岁的年龄组中,与特定种族和原生病诊断 (高血压,血球炎) 相关的死亡风险较高.
- 与年轻人群相比,中年人群经历了某些免疫抑制疗法 (基于sirolimus) 对死亡风险的缓解作用.
结论:
- 接受者年龄层显著改变了非老年成人移植接受者特定危险因素和全因死亡率之间的关联.
- 根据年龄的风险分层对于优化脏移植接受者的结果至关重要.
- 对特定年龄的管理策略进行进一步的研究是有必要的.
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
81
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
81
01:11Renal Failure: Dose Adjustments
79
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
79